Krishnan Patel, MD, MHS
@krishnan_patel
Followers
133
Following
19
Media
0
Statuses
27
Academic Radiation Oncologist. All views are my own and not reflective of my employer.
Joined May 2016
Check out our recent review on enhanced systemic therapy for localized prostate cancer now freely available: A big thanks to our team (@melissaabel20, @SBasourakos, @DeborahCitrin) and Ravi (@Dr_RaviMadan) for his leadership on this one!.
3
4
15
RT @radiolobt: 2025 summary of our original research articles in #prostatecancer .🟢🟢🟢🟢🔵🟠🟡🟡🟡⚪️⚪️⚪️⚪️🟣🟣🟣🟣🟣🟣🟣🟣.(published=🟢, accepted=🔵, revis….
0
1
0
RT @sophia_kamran: @PaulSargos ; @Achard_Verane ; @a_dalpra ; @abhiAsolanki ; @drjefstathiou ; @krishnan_patel ; @Dr_RaviMadan ; @DeborahCi….
0
4
0
Work is in progress to enhance this analysis with individual patient level data until @neildesai2005 and @aleberlin2 can report the results of NRGOnc’s NRG GU010 which will hopefully will hopefully give us a more intelligent way of selecting ADT intensity for IR prostate cancer.
1
0
4
Thanks @ASTRO_org for featuring our article (PMID: 39922318). I hope it will help to help practicing physicians understand, discuss, and recommend ADT in patients with intermediate-risk prostate cancer, especially in cases on the margin of the FIR and UIR stratification.
3
2
21
RT @ASTRO_org: Does short-term ADT continue to show benefit after the negative results of NRG/RTOG 0815? @krishnan_patel, @DrSpratticus, @t….
0
13
0
RT @jryckman3: 🎉 Excited to share our latest work: RadOncCalc – A Mobile-Friendly Tool to Enhance Radiation Oncology Practice 📱⚛️. How does….
0
99
0
RT @radiolobt: 🎉Excited to share our new publication "Evaluating deep learning and radiologist performance in volumetric prostate cancer an….
0
10
0
RT @Davicioni: Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncolo… https:/….
0
3
0
RT @NEJM_AI: In the most comprehensive head-to-head comparison of modern AI-based LLMs for application in oncology, a significant heterogen….
0
18
0
RT @ASTRO_org: New in #practicalRO: Target Volume Optimization for Localized Prostate Cancer. #radonc
https://t.co/….
0
15
0
RT @urotoday: Phase I trial investigates salvage SBRT, revealing promising biochemical control but highlighting significant moderate-grade….
0
1
0
RT @urotoday: Phase I trial investigates salvage SBRT, revealing promising biochemical control but highlighting significant moderate-grade….
0
1
0